Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients

Clinical trial NCT01625286 · COMPLETED

Trial details

NCT number: NCT01625286
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Breast Cancer ER+ve Advanced or Metastatic Breast Cancer

Start date: 2012-10-03
Primary completion: 2017-01-28
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.